Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, MulticEntre, Double-Blind, THree-Arm, Placebo and Active Control Efficacy and SafetY STudy to Evaluate Verinurad combined with Allopurinol in Heart Failure with Preserved Ejection Fraction

Next Previous
Trial Profile

A Phase 2, MulticEntre, Double-Blind, THree-Arm, Placebo and Active Control Efficacy and SafetY STudy to Evaluate Verinurad combined with Allopurinol in Heart Failure with Preserved Ejection Fraction

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Allopurinol (Primary) ; Verinurad (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms AMETHYST
  • Sponsors AstraZeneca; AstraZeneca AB

Most Recent Events

  • 22 Jun 2022 This trial has been completed in Slovakia, according to European Clinical Trials Database record. (29 Apr 2022)
  • 30 May 2022 Status changed from active, no longer recruiting to completed.
  • 26 May 2022 This trial has been completed in Austria (End Date: 29 April 2022) according to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top